about
Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthaseDetermination of protonation constants of some fluorinated polyamines by means of 13C NMR data processed by the new computer program HypNMR2000. Protonation sequence in polyamines.Synthesis, chemical and biological studies on new Fe(3+)-glycosilated beta-diketo complexes for the treatment of iron deficiency.Nuclear magnetic resonance as a tool for determining protonation constants of natural polyprotic bases in solution.Distamycin A and derivatives as synergic drugs in cisplatin-sensitive and -resistant ovarian cancer cells.Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells.Spermidine/spermine N1-acetyltranferase modulation by novel folate cycle inhibitors in cisplatin-sensitive and -resistant human ovarian cancer cell lines.Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells.Studies on the anti-proliferative effects of novel DNA-intercalating bipyridyl-thiourea-Pt(II) complexes against cisplatin-sensitive and -resistant human ovarian cancer cells.Muscle phosphoglycerate mutase (PGAM) deficiency in the first Caucasian patient: biochemistry, muscle culture and 31P-MR spectroscopy.Quantitative mathematical expressions for accurate in vivo assessment of cytosolic [ADP] and DeltaG of ATP hydrolysis in the human brain and skeletal muscle.In vivo (31)P-MRS assessment of cytosolic [Mg(2+)] in the human skeletal muscle in different metabolic conditions.Internalization and Stability of a Thymidylate Synthase Peptide Inhibitor in Ovarian Cancer CellsCorrelation and multivariate analyses of the spectroscopic data in 4′-substituted 4-nitrodiphenylsulfonesInhibition of cell growth by accumulated spermine is associated with a transient alteration of cell cycle progression
P50
Q27671027-F7968ABE-461E-45D3-8D2B-B4C3CF87B2ABQ30809659-789D64FA-D80C-48AC-B8BB-EB576D0D083FQ31153732-AB571A23-08A6-4BB5-B3E6-E71A49A7548CQ36795081-35E6F226-4200-497D-94DA-53AAE5EE4AD3Q38332903-8C08EAB0-7540-49ED-AEB5-5019DEBD5E3FQ39117366-3F63151B-D751-4592-AF16-473250AFF02FQ39759754-0D198C82-F91E-4AB5-9D74-CE2AB5013DF5Q39850756-F3879E8E-48EA-4445-B031-79C3CEBC71E0Q40035162-FF1DBB6A-879D-448F-BE97-EE5C5AD47DD3Q46225665-5221B0C8-34F8-44E8-889D-3A7B041CA3FBQ46543860-F492706C-8F1D-43DD-A8CD-AF153DEDDFA6Q52076084-71ED50C0-DF04-4C60-B126-AB707FD263F9Q57951106-F415B1D8-4AC8-4D34-A3C1-A8F96C445E55Q59614491-7D20038B-30E9-4643-8A8E-405609D129BBQ71123268-6447383A-7EEC-4F25-A927-AE50020922FD
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Chiara Frassineti
@ast
Chiara Frassineti
@en
Chiara Frassineti
@es
Chiara Frassineti
@nl
type
label
Chiara Frassineti
@ast
Chiara Frassineti
@en
Chiara Frassineti
@es
Chiara Frassineti
@nl
prefLabel
Chiara Frassineti
@ast
Chiara Frassineti
@en
Chiara Frassineti
@es
Chiara Frassineti
@nl
P106
P1153
6603600623
P21
P31
P496
0000-0001-7563-7661